Table II.
Comparison of biochemical index (mean ± SD) between the two groups after 7-day treatment.
| Biochemical index | Control group | HEMO group | t value | P-value |
|---|---|---|---|---|
| ALT | 63.32±16.36 | 50.22±15.22 | 3.196 | 0.0023 |
| AST | 70.56±16.39 | 59.36±15.88 | 2.679 | 0.0096 |
| TBIL | 20.69±5.78 | 12.36±4.25 | 6.281 | <0.0001 |
| ALB | 36.58±7.55 | 40.35±6.36 | 2.075 | 0.0424 |
| WBC | 8.46±5.11 | 6.02±3.21 | 2.177 | 0.0335 |
| RBC | 3.98±2.12 | 4.88±1.09 | 2.203 | 0.0477 |
| PLT | 178.66±50.63 | 190.88±56.21 | 0.886 | 0.3793 |
| Serum amylase | 256.98±45.32 | 102.23±55.36 | 11.90 | <0.0001 |
| Urine amylase | 626.36±69.89 | 400.56±85.96 | 11.22 | <0.0001 |
| BUN | 12.88±4.21 | 7.65±3.26 | 5.322 | <0.0001 |
| Scr | 165.23±56.44 | 120.36±57.01 | 3.058 | 0.0034 |
P<0.05, there were significant differences in biochemical index between the two groups, and the clearance of CVVH group was better than that in the control group. ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin; ALB, albumin; WBC, white blood cell; RBC, red blood cell; PLT, platelets; BUN, blood urea nitrogen; Scr, creatinine; CVVH, continuous veno-venous hemofiltration.